Search alternatives:
larger decrease » marked decrease (Expand Search)
data decrease » rate decreased (Expand Search), deaths decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
larger decrease » marked decrease (Expand Search)
data decrease » rate decreased (Expand Search), deaths decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
201
-
202
-
203
Annual treatment frequencies in all eyes.
Published 2025“…Outpatient visit frequency also significantly declined from 11.5 ± 4.3 visits in the year before surgery to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g004" target="_blank">Fig 4</a>).…”
-
204
Annual number of outpatient visits in all eyes.
Published 2025“…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
-
205
Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups.
Published 2025“…These values significantly decreased in the first postoperative year to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0, and 3.1 ± 2.8; in the second year to 2.1 ± 2.8, 0.4 ± 1.0, 0.0, 0.1 ± 0.3, and 2.6 ± 2.8; and in the third year to 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 (Kruskal–Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g007" target="_blank">Fig 7</a>). …”
-
206
Annual treatment frequencies in recurrence and non-recurrence groups.
Published 2025“…These significantly decreased to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0.0, and 3.1 ± 2.8 in the first year; 2.1 ± 2.8, 0.4 ± 1.0, 0, 0.1 ± 0.3, and 2.6 ± 2.8 in the second year; and 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 in the third year (Kruskal–Wallis test, p < 0.001; Dunn’s test, *P < 0.05, **P < 0.01). …”
-
207
-
208
Participant recruitment process flowchart.
Published 2025“…The risk of HDL-C appeared to decrease in the third quartile of pepper consumption (HR: 1, 0.97, 0.87, 1.03, P-trend = 0.008).…”
-
209
Participant recruitment process flowchart.
Published 2025“…The risk of HDL-C appeared to decrease in the third quartile of pepper consumption (HR: 1, 0.97, 0.87, 1.03, P-trend = 0.008).…”
-
210
Participants enrollment.
Published 2025“…<div><p>Hypertension is a widespread and life-threatening condition affecting one-third of adults globally. …”
-
211
KAP assessment scores (n = 422).
Published 2025“…<div><p>Hypertension is a widespread and life-threatening condition affecting one-third of adults globally. …”
-
212
-
213
Flow chart for inclusion and exclusion criteria.
Published 2025“…Children breastfed into their third year of life were more likely to experience underweight and stunting, while breastfeeding during this period was associated with a lower likelihood of wasting.…”
-
214
-
215
-
216
-
217
Sampling process.
Published 2024“…For men patients, direct medical costs were $5351 [4649, 6053] and $4234 [2880, 5588] for women in the first year after the event, $221 [–229, 671] for men and $226 [–727, 1179] for women in the second year, and $11 [–356, 377] for men and $-24 [–612, 564] for women in the third year. This decrease was observed for both men and women, with higher costs for men. …”
-
218
-
219
-
220
Engineering an Electrospun Composite Ureteral Stent Based on PLGA with Antibacterial Properties and Tailored Mechanical Strength
Published 2025“…Mono/three-layer electrospun mats were prepared from pure PLGA and PLGA/LDH (3% LDH) with different fiber orientations to control the usual shrinkage of PLGA mats. A third composite with LDH and 0.5% chitosan was developed to enhance the antibacterial properties of the mats in synergy with Zn ions of LDH. …”